Outsourcing: Analysis and developments of contract service providers to the pharmaceutical and biotechnology industries - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Outsourcing
Contract manufacturing organizations (CMOs) and contract research organizations (CROs). Global sourcing of pharma ingredients and services. Trends and challenges for the biopharmaceutical and pharmaceutical industries.

Outside Looking In

November 1, 2014

Pharmaceutical Technology

European CDMOs want into the US market, but entry options are limited.

CMO Industry Thins Out

October 2, 2014

Pharmaceutical Technology

The trend of exits from the CMO industry looks to be gaining momentum.

Pharma Outsourcing Driving Need for Cloud-Based Services

September 29, 2014

PTSM: Pharmaceutical Technology Sourcing and Management

Multidirectional collaboration is critical for the new pharma business model; cloud-based information services can offer a communications alternative.

Outsourcing Perspectives from Catalent Pharma Solutions

September 3, 2014

Experts at Catalent Pharma Solutions provided commentary on the evolving role of contract services in analytical services, biologics drug development and manufacturing, and solid/semi-solid dosage development and manufacturing.

Outsourcing Perspectives from PPD

September 3, 2014

Experts from PPD provided commentary on the evolving role of contract services in analytical services.

Outsourcing Perspectives from John S. Ross of Metrics Contract Services

September 3, 2014

John S. Ross, executive vice president at Metrics Contract Services, provided commentary on the evolving role of contract services in solid/semi-solid dosage development and manufacturing.

Outsourcing Perspectives from Andrew Strong of Kalon Biotherapeutics

September 3, 2014

Andrew Strong, president and CEO of Kalon Kalon Biotherapeutics, provided commentary on the evolving role of contract services in biologics drug development and manufacturing.

Outsourcing Perspectives from Franco Negron of Patheon Inc.

September 3, 2014

Franco Negron, vice president of North America operations and integration at Patheon Inc., provided commentary on the evolving role of contract services in solid/semi-solid dosage development and manufacturing.

Outsourcing Perspectives from Ron Connolly of Frontage Labs

September 3, 2014

Ron Connolly, vice president of commercial operations at Frontage Labs, provided commentary on the role of contract services in analytical services.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
Click here